- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Johnson & Johnson Ratings Report.
A KeyBanc Capital Markets analyst increases his price target on the stock to $221 from $199.
Stock losses accelerate on Thursday as Deutsche Bank and Wells Fargo drag on the financials sector.
The little-guy investing group the Bogleheads is back.
As consumer confidence and health care spending soar, Johnson & Johnson is becoming one of the best total return packages available.